Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

This study has been completed.
Sponsor:
Collaborators:
Roche Pharma AG
Ministry of Health, Thailand
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT00477048
First received: May 20, 2007
Last updated: February 18, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)